Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Saved in:
| Title: | Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity. |
|---|---|
| Authors: | Omer N; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel., Giladi N; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Gurevich T; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Bar-Shira A; Genetic Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel., Gana-Weisz M; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Glinka T; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Goldstein O; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Kestenbaum M; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Neurology Department, Meir Medical Center, Kfar-Saba, Israel., Cedarbaum JM; Biogen Inc., Cambridge, Massachusetts, USA.; Coeruleus Clinical Sciences LLC, Woodbridge, Connecticut, USA., Mabrouk OS; Biogen Inc., Cambridge, Massachusetts, USA., Fraser KB; Biogen Inc., Cambridge, Massachusetts, USA., Shirvan JC; Biogen Inc., Cambridge, Massachusetts, USA., Orr-Urtreger A; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel., Mirelman A; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Thaler A; Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel.; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel. |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Jan; Vol. 37 (1), pp. 190-195. Date of Electronic Publication: 2021 Sep 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1531-8257 |
|---|---|
| DOI: | 10.1002/mds.28792 |
